Research Progress: APDA-funded research at the International Congress of Parkinson’s Disease and Movement Disorders

Research Progress: APDA-funded research at the International Congress of Parkinson’s Disease and Movement Disorders I just returned from the International Congress of Parkinson’s Disease and Movement Disorders (MDS) that took place Sept 22-Sept 26, 2019 in Nice, France. The meeting attracts scientists and clinicians from around the world who work in the field of Parkinson’s disease […]

Read More

Let’s talk about brain donation

Let’s talk about brain donation One of the most fundamental ways for scientists to learn about Parkinson’s disease (PD) as well as other brain disorders, is by studying the brain tissue of people with these diseases. There is never too much of this extremely valuable material for research studies.  While there are major strides in […]

Read More

APDA ANNOUNCES $1.7 MILLION IN NEW PARKINSON’S DISEASE RESEARCH GRANTS. FUNDING ENABLES 10 RESEARCHERS TO CONDUCT IMPACTFUL RESEARCH.

APDA announces funding for 2019-2020 grants It is that time of year – when APDA announces our research grantees for the 2019-2020 fiscal year. We are very proud of our grant recipients who each has a unique idea that will hopefully benefit the entire Parkinson’s disease (PD) community. This year APDA has awarded $1.7 million […]

Read More

New medication, Istradefylline, gets approved for Parkinson’s disease

New medication, Istradefylline, gets approved for Parkinson’s disease On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval for Istradefylline, a new medication for Parkinson’s disease (PD) to be used as an add-on treatment to carbidopa/levodopa for those experiencing OFF episodes. (For more information on OFF periods in PD, please see this recent APDA […]

Read More